Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Subscribe
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Subscribe
FREE
29 Aug 2017
Reducing the Harmful Effects of Immune Cells
DISRUPTION of a key enzyme involved in immune cell-mediated damage has been researchers’ focus, in the hope of discovering a novel treatment target for a…
3
Mins
25 Aug 2017
Mesothelioma: A Dormant Threat
The industrialised world is truly a marvel; through years of innovation and invention, society has been rewarded with extreme technological advances.
24 Aug 2017
Immatics Initiates Personalized Adoptive Cellular Therapy in Patients with Relapsed And/Or Refractory Solid Cancers Using Its Pioneering Target Warehouse
Immatics announced enrolment of patients into a phase I trial of its first adoptive cellular therapy (ACT) IMA101.
24 Aug 2017
Orchard Therapeutics Announces That OTL-101 Has Received a Designation as Promising Innovative Medicine by UK’s Regulatory Agency
London, UK, 22 August, 2017 – Orchard Therapeutics Limited (“Orchard”), a clinical-stage biotechnology company developing transformative gene therapies…
21 Aug 2017
Action-Packed August
Here in the EMJ offices, August would best be described by the team as a whirlwind, with not one, but six brand new publications ready for you to choose…
21 Aug 2017
Kale Increases Cognitive Concentration
LUTEIN, a pigment found in kale, spinach, avocados, and eggs, may work to rejuvenate cognitive function, according to a study from the University of…
21 Aug 2017
Biological Age Accelerated by Bipolar Disorder
RESEARCH conducted at Kings College London, London, UK and Icahn School of Medicine, Mount Sinai, New York City, New York, USA has shown a link between…
17 Aug 2017
Introducing EMJ Reproductive Health 3.1
United Kingdom, August 17, 2017: A warm welcome to the 2017 EMJ Reproductive Health eJournal! This instalment gives a complete review of…
2
Mins
17 Aug 2017
Can A Second Dose of Kisspeptin Safely Improve Oocyte Maturation in Women at High Risk of Ovarian Hyperstimulation Syndrome?
Kisspeptin is a novel neuropeptide that came to prominence in the field of fertility in 2003, when it was discovered that genetic mutations causing…
6
Mins
17 Aug 2017
Editor’s Pick: Selection of Appropriate Tools for Evaluating Obesity in Polycystic Ovary Syndrome Patients
Patients with polycystic ovary syndrome (PCOS) have unique endocrine and metabolic characteristics, whereby the incidence and potentiality of obesity, as…
←
1
2
3
…
768
769
770
771
772
773
774
…
994
995
996
→